1. Home
  2. VIR vs ARCO Comparison

VIR vs ARCO Comparison

Compare VIR & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

N/A

Current Price

$10.92

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo Arcos Dorados Holdings Inc. Shares

ARCO

Arcos Dorados Holdings Inc. Shares

N/A

Current Price

$7.72

Market Cap

1.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
VIR
ARCO
Founded
2016
2007
Country
United States
Uruguay
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2019
2011

Fundamental Metrics

Financial Performance
Metric
VIR
ARCO
Price
$10.92
$7.72
Analyst Decision
Strong Buy
Hold
Analyst Count
7
2
Target Price
$19.43
$8.60
AVG Volume (30 Days)
1.9M
873.6K
Earning Date
05-06-2026
05-20-2026
Dividend Yield
N/A
3.23%
EPS Growth
17.49
N/A
EPS
N/A
N/A
Revenue
$68,556,000.00
N/A
Revenue This Year
$270.22
$12.56
Revenue Next Year
N/A
$3.48
P/E Ratio
N/A
$7.26
Revenue Growth
N/A
N/A
52 Week Low
$4.75
$6.54
52 Week High
$11.94
$9.75

Technical Indicators

Market Signals
Indicator
VIR
ARCO
Relative Strength Index (RSI) 51.55 37.43
Support Level $8.43 $7.44
Resistance Level $10.67 $8.20
Average True Range (ATR) 0.53 0.20
MACD -0.11 -0.03
Stochastic Oscillator 16.19 3.91

Price Performance

Historical Comparison
VIR
ARCO

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About ARCO Arcos Dorados Holdings Inc. Shares

Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Its menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others. It generates maximum revenue from Brazil.

Share on Social Networks: